ELISIGENETICS
LIVE

Serial Number

99769457

Owner

ELISIGEN INC.

Attorney

KEITH R. OBERT

Filing Date

Apr 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ELISIGENETICS Trademark

Serial Number: 99769457

ELISIGENETICS is a trademark filed by ELISIGEN INC. on April 16, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

ELISIGEN INC. (2 trademarks)

402-2, Sanhakgwan, 145 Anam-ro
Seoul 02841 , KR

Entity Type: 99

Trademark Details

Filing Date

April 16, 2026

Registration Date

Not Registered

Goods & Services

Wholesale distributorships featuring pharmaceutical preparations for the treatment of sensory organ disorders; Wholesale distributorships featuring pharmaceutical preparations for the treatment of peripheral nervous system disorders; Wholesale distributorships featuring pharmaceutical preparations for the treatment of central nervous system disorders; Wholesale distributorships featuring analgesics; Wholesale distributorships featuring immunomodulators; Wholesale distributorships featuring vaccines; Wholesale distributorships featuring chemical preparations for use in the manufacture of pharmaceuticals; Wholesale distributorships featuring biological preparations for medical and veterinary purposes; Wholesale distributorships featuring pharmaceutical preparations for the treatment of allergies; Wholesale distributorships featuring cosmetics

Scientific research in the field of pharmacogenetics; Research and development in the field of gene-based pharmaceuticals; Research and development services in the field of gene expression systems; Gene therapy research; Research in the field of gene editing technology; Scientific research in the field of genetics; Research and development in the field of therapeutic peptides; Pharmaceutical research and development; Research and development services in the field of cosmetics; Food research

Nucleic acid sequences for medical and veterinary purposes; Synthetic peptides for pharmaceutical purposes; Cells for medical purposes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of tinnitus; Pharmaceutical preparations for the treatment of central nervous system disorders; Pain relief medication; Analgesics; Vaccines; Tranquilizers; Diagnostic preparations for medical purposes; Drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment of allergies

Filing History

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 16, 2026 MAFR
NEW APPLICATION ENTERED
Apr 16, 2026 NWAP